Aiflp inhibits development of fluconazole resistance in yeastFANSHENG KONG; XIMIN LIU; NING HUANG et al.Annals of microbiology. 2012, Vol 62, Num 4, pp 1461-1466, issn 1590-4261, 6 p.Article

Determination of the in vitro activity of fluconazole against yeast strains using HPLCCASALINUOVO, Ida Antonia; DI PIERROTS, Donato; BONELLI, Graziano et al.Annals of microbiology. 2008, Vol 58, Num 4, pp 755-760, issn 1590-4261, 6 p.Article

Antileishmanial efficacy of fluconazole and miltefosine in combination with an immunomodulator-picrolivSHAKYA, Nishi; SANE, Shraddha A; GUPTA, Suman et al.Parasitology research (1987). 2011, Vol 108, Num 4, pp 793-800, issn 0932-0113, 8 p.Article

Heteroresistance of Cryptococcus gattii to FluconazoleVARMA, A; KWON-CHUNG, K. J.Antimicrobial agents and chemotherapy. 2010, Vol 54, Num 6, pp 2303-2311, issn 0066-4804, 9 p.Article

Studies on the characteristics of drug-loaded gelatin nanoparticles prepared by nanoprecipitationEUN JU LEE; SAEED AHMAD KHAN; JOONG KON PARK et al.Bioprocess and biosystems engineering (Print). 2012, Vol 35, Num 1-2, pp 297-307, issn 1615-7591, 11 p.Conference Paper

Additional investigation on the potentiation of phenytoin teratogenicity by fluconazoleTIBONI, Gian Mario; GIAMPIETRO, Franca; ANGELUCCI, Stefania et al.Toxicology letters. 2003, Vol 145, Num 3, pp 219-229, issn 0378-4274, 11 p.Article

Shifting patterns in the epidemiology of nosocomial Candida infectionsSNYDMAN, David R.Chest. 2003, Vol 123, Num 5, pp 500S-503S, issn 0012-3692, SUPArticle

Conidiobolomycose, succès du traitement médico-chirurgical = Conidiobolomycosis, success of the medico-surgical treatmentESTRAN, C; CASTILLO, L; MARTY, P et al.Journal de mycologie médicale (Paris). 2005, Vol 15, Num 2, pp 103-107, issn 1156-5233, 5 p.Article

RAPID DESENSITIZATION TO FLUCONAZOLE (DIFLUCAN)RANDOLPH, Chris; KAPLAN, Cynthia; FRASER, Barbara et al.Annals of allergy, asthma, & immunology. 2008, Vol 100, Num 6, pp 616-617, issn 1081-1206, 2 p.Article

The Antifungal Activity of Sarcococca saligna Ethanol Extract and its Combination Effect with Fluconazole against Different Resistant Aspergillus SpeciesKAMYAR MOLLAZADEH MOGHADDAM; ARFAN, Mohammad; RAFIQUE, Jamal et al.Applied biochemistry and biotechnology. 2010, Vol 162, Num 1, pp 127-133, issn 0273-2289, 7 p.Article

Susceptibility of Candida biofilms to histatin 5 and fluconazoleKONOPKA, Krystyna; DOROCKA-BOBKOWSKA, Barbara; GEBREMEDHIN, Senait et al.Antonie van Leeuwenhoek. 2010, Vol 97, Num 4, pp 413-417, issn 0003-6072, 5 p.Article

Recrystallization of fluconazole using the supercritical antisolvent (SAS) processHEE JUN PARK; KIM, Min-Soo; LEE, Sibeum et al.International journal of pharmaceutics. 2007, Vol 328, Num 2, pp 152-160, issn 0378-5173, 9 p.Article

Upc2p-associated differential protein expression in Candida albicansHOEHAMER, Christopher F; CUMMINGS, Edwin D; HILLIARD, George M et al.Proteomics (Weinheim. Print). 2009, Vol 9, Num 20, pp 4726-4730, issn 1615-9853, 5 p.Article

Fluconazole inhibits human adrenocortical steroidogenesis in vitroDER PAS, R. Van; HOFLAND, L. J; HOFLAND, J et al.Journal of endocrinology. 2012, Vol 215, Num 3, pp 403-412, issn 0022-0795, 10 p.Article

Antifungal susceptibility testing of fluconazole by flow cytometry correlates with clinical outcomeWENISCH, Christoph; MOORE, Caroline B; KRAUSE, Robert et al.Journal of clinical microbiology (Print). 2001, Vol 39, Num 7, pp 2458-2462, issn 0095-1137Article

Plasma and tissue concentrations of fluconazole and their correlation to breakpointsPITTROW, L; PENK, A.Mycoses. 1997, Vol 40, Num 1-2, pp 25-32, issn 0933-7407Article

Dosage adjustment of fluconazole during continuous renal replacement therapy (CAVH, CVVH, CAVHD, CVVHD)PITTROW, L; PENK, A.Mycoses. 1999, Vol 42, Num 1-2, pp 17-19, issn 0933-7407Article

Stability of Mueller-Hinton agar supplemented with glucose and methylene blue for disk diffusion testing of fluconazole and voriconazolePFALLER, M. A; BOYKEN, L; MESSER, S. A et al.Journal of clinical microbiology (Print). 2004, Vol 42, Num 3, pp 1288-1289, issn 0095-1137, 2 p.Article

In vitro activity of fluconazole, voriconazole and caspofungin against clinical yeast isolatesMAIDA, C. M; MILICI, M. E; OLIVERI, S et al.Journal of chemotherapy. 2007, Vol 19, Num 3, pp 277-282, issn 1120-009X, 6 p.Article

Interaction of Azole Compounds with DOPC and DOPC/Ergosterol Bilayers by Spin Probe EPR Spectroscopy: Implications for Antifungal ActivityCICOGNA, Francesca; PINZINO, Calogero; CASTELLANO, Sabrina et al.The Journal of physical chemistry. B. 2013, Vol 117, Num 40, pp 11978-11987, issn 1520-6106, 10 p.Article

In Vitro Susceptibility of the Yeast Pathogen Cryptococcus to Fluconazole and Other Azoles Varies with Molecular GenotypeHIN SIONG CHONG; DAGG, Rebecca; MALIK, Richard et al.Journal of clinical microbiology (Print). 2010, Vol 48, Num 11, pp 4115-4120, issn 0095-1137, 6 p.Article

Chemosensitization of fluconazole resistance in Saccharomyces cerevisiae and pathogenic fungi by a D-octapeptide derivativeNIIMI, K; HARDING, D. R. K; MONK, B. C et al.Antimicrobial agents and chemotherapy. 2004, Vol 48, Num 4, pp 1256-1271, issn 0066-4804, 16 p.Article

Utility of real-time antifungal susceptibility testing for fluconazole in the treatment of candidemiaBADDLEY, John W; PATEL, Mukesh; JONES, Marga et al.Diagnostic microbiology and infectious disease. 2004, Vol 50, Num 2, pp 119-124, issn 0732-8893, 6 p.Article

Repeated isolation of Cryptococcus laurentii from the oropharynx of an immunocompromized patientBAUTERS, T. G. M; SWINNE, D; BOEKHOUT, T et al.Mycopathologia (1975). 2002, Vol 153, Num 3, pp 133-135, issn 0301-486XArticle

Susceptibility testing of fluconazole by the NCCLS broth macrodilution method, E-test, and disk diffusion for application in the routine laboratoryVANDENBOSSCHE, Inge; VANEECHOUTTE, Mario; VANDEVENNE, Marleen et al.Journal of clinical microbiology (Print). 2002, Vol 40, Num 3, pp 918-921, issn 0095-1137Article